1 year return (CAGR)
-28.84%
Vyne Therapeutics Inc Exchange (NASDAQ, USD)
VYNE
30.45
-0.01 (-1.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-54.25%
5 year return (CAGR)
-59.48%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
22.55M
Price/Sales
39.56
Ent value
914.53K
Price/Book
0.81
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-66.27%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.69 |
| Daily high | 0.69 |
| Daily low | 0.67 |
| Daily Volume | 72K |
| All-time high | 10892.16 |
| 1y analyst estimate | 2.00 |
| Beta | 2.01 |
| EPS (TTM) | -0.50 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| VYNE | S&P500 | |
| Current price drop from All-time high | -99.72% | -3.96% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 9 Sep 2025 | 9 Mar 2009 |
| Avg drop from high | -93.25% | -10.68% |
| Avg time to new high | 350 days | 12 days |
| Max time to new high | 2056 days | 1805 days |
News
No items found